Treatment discontinuation of immunotherapy in patients with head and neck squamous cell carcinoma experiencing complete or nearly complete remission

被引：0
作者：
Klinghammer, K. [1 ]
Heinze, B. [1 ]
Ivanyi, P. [2 ]
Laban, S. [3 ]
Raguse, J. -D [4 ]
Pogorzelski, M. [5 ]
Keller, U. [1 ]
Keilholz, U. [6 ]
Hahn, D. [7 ]
机构：
[1] Charite, Hematol Oncol Tumor Immunol, Berlin, Germany
[2] MHH, Hannover, Germany
[3] Univ Klinikum Ulm, Ulm, Germany
[4] Fachklin Hornheide, Munster, Germany
[5] WTZ Essen, Essen, Germany
[6] Charite, CCCC, Berlin, Germany
[7] Klinikum Stuttgart, Stuttgart, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P697
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
[41]   Novel immunotherapy combinations in head and neck squamous cell carcinoma [J].
Kankotia, Shyam ;
Park, Soyun ;
Thomas, Jacob .
CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) :209-217
[42]   Immunotherapy in head and neck squamous cell carcinoma: An updated review [J].
Parmar, K. ;
Mohamed, A. ;
Vaish, E. ;
Thawani, R. ;
Cetnar, J. ;
Thein, K. Z. .
CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
[43]   Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma [J].
Bell, R. Bryan ;
Leidner, Rom ;
Feng, Zipei ;
Crittenden, Marka R. ;
Gough, Michael J. ;
Fox, Bernard A. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2015, 73 (12) :S107-S115
[44]   The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches [J].
Economopoulou, Panagiota ;
Kotsantis, Ioannis ;
Psyrri, Amanda .
ESMO OPEN, 2016, 1 (06)
[45]   The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) [J].
Cohen, Ezra E. W. ;
Bell, R. Bryan ;
Bifulco, Carlo B. ;
Burtness, Barbara ;
Gillison, Maura L. ;
Harrington, Kevin J. ;
Quynh-Thu Le ;
Lee, Nancy Y. ;
Leidner, Rom ;
Lewis, Rebecca L. ;
Licitra, Lisa ;
Mehanna, Hisham ;
Mel, Loren K. ;
Raben, Adam ;
Sikora, Andrew G. ;
Uppaluri, Ravindra ;
Whitworth, Fernanda ;
Zandberg, Dan P. ;
Ferris, Robert L. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[46]   Pseudoprogression in the era of immunotherapy-based strategies for recurrent head and neck squamous cell carcinoma achieving complete response: A case report [J].
Zhou, Jiawei ;
Luo, Jie ;
Gu, Jiajia ;
Zhang, Jingyuan ;
Gu, Dayong ;
Zhang, Xiuming ;
Wang, Feijiang ;
He, Xia ;
Wu, Lirong .
MEDICINE, 2023, 102 (31) :E33797
[47]   Complete Remission of ossar metastatic Squamous Cell Carcinoma under Pembrolizumab [J].
Pietschke, K. ;
Lomberg, D. ;
Koechel, A. ;
Mueller, A. ;
Eigentler, T. ;
Leiter-Stoeppke, U. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 :73-73
[48]   Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck [J].
Haddad, R ;
Tishler, R ;
Wirth, L ;
Norris, CM ;
Goguen, L ;
Sullivan, C ;
O'Donnell, L ;
Li, Y ;
Posner, M .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2006, 132 (06) :678-681
[49]   Cetuximab in the treatment of squamous cell carcinoma of the head and neck [J].
Specenier, Pol ;
Vermorken, Jan B. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) :511-524
[50]   Afatinib in the treatment of head and neck squamous cell carcinoma [J].
Ferrarotto, Renata ;
Gold, Kathryn A. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (01) :135-143
12345